Authors: Dr Amy Stanway, Department of Dermatology, Waikato Hospital, Hamilton, New Zealand, 2004. Copy edited by Gus Mitchell. DermNet Update October 2021
Guttate psoriasis is a form of acutepsoriasis described as a shower of small, pink-red, scaly ‘raindrops’ that has fallen over the body.
Guttate psoriasis
Guttate psoriasis
Guttate psoriasis
Who gets guttate psoriasis?
Guttate psoriasis tends to affect children and young adults; it is the second most common form of psoriasis in children after chronic plaque psoriasis. Both sexes and all races can develop guttate psoriasis. It is often the first presentation of psoriasis for an individual, but can also be seen in those with known chronic psoriasis.
What causes guttate psoriasis?
Guttate psoriasis typically develops 1–2 weeks after a streptococcal infection of the upper respiratory tract, particularly tonsillitis, or other sites such as perianal streptococcal dermatitis. Beta-haemolytic streptococci can directly stimulate skin-homing T-cellproliferation in the tonsils.
Guttate psoriasis has been reported to follow SARS-CoV-2 infection (COVID-19) and other viral infections such as coxsackievirus. [see Enteroviral infections]
What are the clinical features of guttate psoriasis?
Acute onset over days
Numerous small patches (<1 cm)
Pink, scaly, thin patches or plaques of psoriasis
Scale can be subtle in early lesions
Widespread lesions predominantly over the trunk and limbs
Lesions on the face, scalp, and ears tend to be faint and short-lived
Guttate psoriasis often clears within 3-4 months, even without treatment. Patients with proven streptococcal infection triggering the guttate psoriasis have a good prognosis. However, it may recur with another episode of streptococcal infection.
Guttate psoriasis may become persistent and progress to chronic plaque psoriasis. In a study of over 190,000 patients with guttate psoriasis, 12.5% subsequently developed chronic plaque chronic psoriasis, with half of these cases occurring within one year of their initial presentation of guttate psoriasis.
Bibliography
Dupire G, Droitcourt C, Hughes C, Le Cleach L. Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev. 2019;3(3):CD011571. doi:10.1002/14651858.CD011571.pub2. Journal
Gananandan K, Sacks B, Ewing I. Guttate psoriasis secondary to COVID-19. BMJ Case Rep. 2020;13(8):e237367. doi:10.1136/bcr-2020-237367. Journal
Garritsen FM, Kraag DE, de Graaf M. Guttate psoriasis triggered by perianal streptococcal infection. Clin Exp Dermatol. 2017;42(5):536–8. doi:10.1111/ced.13129. PubMed
Jindal R, Chauhan P, Sethi S. Dermoscopic characterization of guttate psoriasis, pityriasis rosea, and pityriasis lichenoides chronica in dark skin phototypes: an observational study. Dermatol Ther. 2021;34(1):e14631. doi:10.1111/dth.14631. PubMed
Kridin, K., de Luca, D. A., Mruwat, N., Ludwig, R. J., & Thaçi, D. (2025). The risk of different subtypes of psoriasis following an episode of guttate psoriasis. Journal of the American Academy of Dermatology, 92(2), 315–316. doi:10.1016/j.jaad.2024.04.082. Journal
Makhecha M, Singh T, Khatib Y. Dermoscopy differentiates guttate psoriasis from a mimicker-pityriasis rosea. Dermatol Pract Concept. 2021;11(1):e2021138. doi:10.5826/dpc.1101a138. PubMed Central
Maruani A, Samimi M, Stembridge N, et al. Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis. Cochrane Database Syst Rev. 2019;4(4):CD011541. doi:10.1002/14651858.CD011541.pub2. Journal
Pfingstler LF, Maroon M, Mowad C. Guttate psoriasis outcomes. Cutis. 2016;97(2):140–4. PubMed
Rouai M, Rabhi F, Mansouri N, Jaber K, Dhaoui R. New-onset guttate psoriasis secondary to COVID-19. Clin Case Rep. 2021;9(7):e04542. doi:10.1002/ccr3.4542. Journal